Table 4.
Hemodialysis | Online Hemodiafiltration Convection Volume Tertiles | P for Trend | |||
---|---|---|---|---|---|
<18.17 L | 18.18–21.95 L | >21.95 L | |||
Total mortality | |||||
crude | 1.0 | 0.95 (0.66–1.38) | 0.83 (0.57–1.22) | 0.62 (0.41–0.93) | 0.010 |
adjusteda | 1.0 | 0.79 (0.53–1.14) | 0.77 (0.51–1.14) | 0.65 (0.42–0.99) | 0.012 |
adjustedb | 1.0 | 0.80 (0.52–1.24) | 0.84 (0.54–1.29) | 0.61 (0.38–0.98) | 0.015 |
Fatal and nonfatal cardiovascular events | |||||
crude | 1.0 | 1.37 (0.94–1.98) | 1.06 (0.72–1.56) | 0.76 (0.50–1.16) | 0.473 |
adjusteda | 1.0 | 1.41 (0.92–2.11) | 0.93 (0.62–1.40) | 0.77 (0.48–1.21) | 0.369 |
adjustedb | 1.0 | 1.35 (0.86–2.11) | 1.04 (0.66–1.62) | 0.72 (0.44–1.19) | 0.475 |
Results reported as HR and 95% confidence interval, from Cox proportional hazards models. Reference is treatment with low-flux hemodialysis.
Adjusted for determinants of mortality, i.e., age, sex, previous vascular disease, diabetes, previous transplantation, spKt/V, baseline eGFR, baseline albumin, baseline creatinine, baseline hematocrit, and use of α- and β-blockers, calcium antagonists, and angiotensin converting inhibitors at baseline (82 missing, 206 deaths, 182 cardiovascular events).
Adjusted for the above-mentioned determinates as well as for center differences (82 missing, 206 deaths, 182 cardiovascular events).